| Literature DB >> 17166723 |
Ronald Palin1, Anton Bom, John K Clark, Louise Evans, Helen Feilden, Andrea K Houghton, Philip S Jones, Brian Montgomery, Mark A Weston, Grant Wishart.
Abstract
A series of 3-phenoxypropyl piperidine benzimidazol-2-one analogues have been discovered as novel NOP receptor agonists. Structure-activity relationships have been explored via N-3 substitution of the benzimidazol-2-one with a range of functionality. The N-methyl acetamide derivative (+)-7f was found to be a high-affinity, potent NOP agonist with greater than 100-fold selectivity over the MOP receptor. Furthermore (+)-7f was shown to be both antinociceptive and sedative when administered iv to rodents.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17166723 DOI: 10.1016/j.bmc.2006.11.030
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641